Olof Idevall-Hagren receives a 5-year grant from the Novo Nordisk Foundation


Olof Idevall-Hagren receives the “Excellence Emerging Investigator Grant – Endocrinology & Metabolism”

The grant awarded to Olaf Idevall-Hagren  will support the project “The β-cell primary cilium is a unique signaling compartment” with 13 million SEK over 5 years.

With this grant the Novo Nordisk Foundation  supports and strengthens the development of young and promising research leaders, and to promote Nordic research at a high international level. The call was targeted starting group leaders with ambitious projects within endocrinology and metabolism that aim to understand the human organism and the mechanisms underlying health and disease at a basic and clinical level.

Read more about Olof’s research here: http://www.mcb.uu.se/res/groups/oih/

Read more about the grant here: https://novonordiskfonden.dk/da/grants/excellence-emerging-investigator-grant-within-endocrinology-and-metabolism-nordic-region/